Get the Stockscreener App
44.62
3.00%
-1.38
After Hours:
44.36
-0.26
-0.58%
Q 32 Bio Inc stock is traded at $44.62, with a volume of 66,084.
It is down -3.00% in the last 24 hours and up +2.62% over the past month.
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.
See More
Previous Close:
$46.00
Open:
$46.05
24h Volume:
66,084
Relative Volume:
0.55
Market Cap:
$536.66M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+2.13%
1M Performance:
+2.62%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$44.08
$47.84
1-Week Range:
$42.16
$48.06
52-Week Range:
$13.59
$53.79
Q 32 Bio Inc Stock (QTTB) Company Profile
Name
Q 32 Bio Inc
Sector
Industry
Phone
781-999-0232
Address
830 WINTER STREET, WALTHAM
Q 32 Bio Inc Stock (QTTB) Latest News
Q32 Bio's SWOT analysis: emerging biotech stock targets inflammatory diseases - Investing.com India
Q32 Bio's SWOT analysis: emerging biotech stock targets inflammatory diseases - Investing.com UK
Ensign Peak Advisors Inc Purchases 38,750 Shares of Q32 Bio Inc. (NASDAQ:QTTB) - MarketBeat
Bank of New York Mellon Corp Makes New $315,000 Investment in Q32 Bio Inc. (NASDAQ:QTTB) - MarketBeat
Bruce K. Posey Sells 1,330 Shares of Qualys, Inc. (NASDAQ:QLYS) Stock - Defense World
QXO (NASDAQ:QXO) Trading Up 4.7% - MarketBeat
Q32 Bio (NASDAQ:QTTB) Trading Down 3.7% - Defense World
Q32 Bio (NASDAQ:QTTB) Shares Down 3.7% - MarketBeat
Stock Surge: Qualigen Therapeutics Inc (QLGN) Closes at 0.17, Marking a -4.84 Increase/Decrease - The Dwinnex
Q32 Bio Inc.(NasdaqGM: QTTB) added to S&P Global BMI Index - Marketscreener.com
Mutual of America Capital Management LLC Trims Stock Position in Qualys, Inc. (NASDAQ:QLYS) - Defense World
Client First Investment Management LLC Purchases New Stake in ProShares Ultra QQQ (NYSEARCA:QLD) - Defense World
Davidson Capital Management Inc. Boosts Holdings in Qualys, Inc. (NASDAQ:QLYS) - Defense World
Inspire Investing LLC Acquires 2,595 Shares of Qualys, Inc. (NASDAQ:QLYS) - Defense World
Choreo LLC Makes New $264,000 Investment in Qualys, Inc. (NASDAQ:QLYS) - Defense World
Q32 Bio (NASDAQ:QTTB) Sees Strong Trading Volume - MarketBeat
Q32 Bio (NASDAQ:QTTB) Sees Strong Trading Volume - Defense World
Q32 Bio (NASDAQ:QTTB) Trading 8.2% Higher - MarketBeat
Harvard Management Co. Inc. Purchases New Stake in Q32 Bio Inc. (NASDAQ:QTTB) - MarketBeat
Q32 Bio Inc. (NASDAQ:QTTB) Receives $68.80 Average PT from Analysts - Defense World
EchoStar (NASDAQ:SATS) Hits New 12-Month High Following Analyst Upgrade - Defense World
Q32 Bio (NASDAQ:QTTB) Trading Down 3.7% - MarketBeat
Q32 Bio (NASDAQ:QTTB) Sets New 52-Week High at $52.64 - MarketBeat
Wells Fargo & Company Begins Coverage on Q32 Bio (NASDAQ:QTTB) - MarketBeat
Q32 Bio Inc. (NASDAQ:QTTB) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Q32 Bio's Stock (NASDAQ:QTTB) Hits 52 Week High As Wells Fargo Initiates With Lofty Price Target - AskTraders
QTTB stock soars to 52-week high, reaching $47.5 - Investing.com India
10 Best Small Cap Stocks to Buy Now in 2024 - MarketBeat
Q32 Bio (NASDAQ:QTTB) Shares Up 3.3% - MarketBeat
Q32 Bio (NASDAQ:QTTB) Sets New 52-Week High at $45.00 - MarketBeat
Wall Street Analysts Think Q32 Bio (QTTB) Could Surge 91.69%: Read This Before Placing a Bet - Yahoo Finance UK
Q32 Bio (NASDAQ:QTTB) Sets New 52-Week High at $43.48 - MarketBeat
Q32 Bio to Participate in Upcoming September Investor Conferences - Elk Valley Times
Q32 Bio to Participate in Upcoming September Investor Conferences - Longview News-Journal
Q32 Bio: High-Risk, High-Reward With Bempikibart And ADX-097 (NASDAQ:QTTB) - Seeking Alpha
bluebird bio Announces Receipt of Expected Notices from Nasdaq - Business Wire
Vanguard Group Inc. Invests $1.84 Million in Q32 Bio Inc. (NASDAQ:QTTB) - MarketBeat
Piper Sandler backs Q32 Bio stock with Overweight rating, highlights key catalysts - Investing.com India
Piper Sandler backs Q32 Bio stock with Overweight rating, highlights key catalysts - Investing.com
Financial Contrast: Q32 Bio (NASDAQ:QTTB) vs. Genmab A/S (OTCMKTS:GNMSF) - Defense World
Q32 Bio director Arthur Tzianabos sells $6.4k in stock By Investing.com - Investing.com Australia
Q32 Bio director Arthur Tzianabos sells $6.4k in stock - Investing.com India
Q32 Bio director Arthur Tzianabos sells $6.4k in stock - Investing.com
Q32 Bio director Arthur Tzianabos sells $6.4k in stock By Investing.com - Investing.com UK
Q32 Bio (NASDAQ:QTTB) Posts Earnings Results, Misses Estimates By $0.42 EPS - Defense World
Q32 Bio: Q2 Earnings Snapshot - Houston Chronicle
Q32 Bio: Q2 Earnings Snapshot - San Antonio Express-News
Q32 Bio: Q2 Earnings Snapshot - San Francisco Chronicle
Q32 Bio Reports Second Quarter 2024 Financial Results and Provides Corporate Update - PR Newswire
Science X Network :: Phys.org, Medical Xpress, Tech Xplore - Science X
Q32 Bio's Skeleton Key May Unlock New Disease Treatments - Mirage News
Q 32 Bio Inc Stock (QTTB) Financials Data
There is no financial data for Q 32 Bio Inc (QTTB). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):